Form 8-K - Current report:
SEC Accession No. 0001213900-15-002954
Filing Date
2015-04-23
Accepted
2015-04-23 16:32:25
Documents
30
Period of Report
2015-04-23
Items
Item 7.01: Regulation FD Disclosure
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 CURRENT REPORT f8k042315_relmadatherap.htm 8-K 24118
2 RELMADA THERAPEUTICS, INC., CORPORATE PRESENTATION. f8k042315ex99i_relmada.htm EX-99.1 23800
3 GRAPHIC slide1.jpg GRAPHIC 49445
4 GRAPHIC slide2.jpg GRAPHIC 151986
5 GRAPHIC slide3.jpg GRAPHIC 121484
6 GRAPHIC slide4.jpg GRAPHIC 142996
7 GRAPHIC slide5.jpg GRAPHIC 100074
8 GRAPHIC slide6.jpg GRAPHIC 104703
9 GRAPHIC slide7.jpg GRAPHIC 118678
10 GRAPHIC slide8.jpg GRAPHIC 109094
11 GRAPHIC slide9.jpg GRAPHIC 55203
12 GRAPHIC slide10.jpg GRAPHIC 137700
13 GRAPHIC slide11.jpg GRAPHIC 127819
14 GRAPHIC slide12.jpg GRAPHIC 76678
15 GRAPHIC slide13.jpg GRAPHIC 51235
16 GRAPHIC slide14.jpg GRAPHIC 130689
17 GRAPHIC slide15.jpg GRAPHIC 110343
18 GRAPHIC slide16.jpg GRAPHIC 66809
19 GRAPHIC slide17.jpg GRAPHIC 54257
20 GRAPHIC slide18.jpg GRAPHIC 150578
21 GRAPHIC slide19.jpg GRAPHIC 116153
22 GRAPHIC slide20.jpg GRAPHIC 75658
23 GRAPHIC slide21.jpg GRAPHIC 32092
24 GRAPHIC slide22.jpg GRAPHIC 166909
25 GRAPHIC slide23.jpg GRAPHIC 63372
26 GRAPHIC slide24.jpg GRAPHIC 37295
27 GRAPHIC slide25.jpg GRAPHIC 106782
28 GRAPHIC slide26.jpg GRAPHIC 124626
29 GRAPHIC slide27.jpg GRAPHIC 121532
30 GRAPHIC slide28.jpg GRAPHIC 66426
  Complete submission text file 0001213900-15-002954.txt   3870237
Mailing Address 546 FIFTH AVENUE, 14TH FLOOR NEW YORK NY 10036
Business Address 546 FIFTH AVENUE, 14TH FLOOR NEW YORK NY 10036 212-702-7163
RELMADA THERAPEUTICS, INC. (Filer) CIK: 0001553643 (see all company filings)

EIN.: 455401931 | State of Incorp.: NV | Fiscal Year End: 0630
Type: 8-K | Act: 34 | File No.: 000-55347 | Film No.: 15788822
SIC: 2834 Pharmaceutical Preparations